Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by davewhoon Jun 30, 2021 9:21pm
461 Views
Post# 33478060

RE:AGM

RE:AGM12.5M shares voted out of 63M and James got 7M. According to the NR approximately 1.3% of shareholders opposed the motions or 820k. Next year Care has their 15M shares and guess who they will be voting for? As for the RS the way I read the TSX rules a shareholder vote is a courtesy not a requirement. It was probably withdrawn so the company can do it with just TSX approval. 
7. Security Consolidations 7.1 All security consolidations are subject to Exchange acceptance. In addition, the Exchange will require Shareholder approval for any security consolidation which, when combined with any other security consolidation conducted by the Issuer within the previous 24 months that was not approved by its Shareholders, would result in a cumulative consolidation ratio of greater than 10 to 1 over such 24 month period. It should be noted that even if the Exchange’s Shareholder approval requirement for a security consolidation is not applicable to a particular security consolidation, the Issuer may still be required to obtain Shareholder approval for the consolidation under applicable corporate laws. 
If I were James I would probably be quite insulted for all the years of hard work he had done. I would do no more interviews, no more live QR's releases. Which are not required by the TSX and I would issue no more NR's or updates unless absolutely required by the TSX.
So congratulations to all no voters on a job not well done. But since I'm not James he can do as he pleases. I suggest all shareholders who voted yes email James and offer their congratulations and confidence. 
<< Previous
Bullboard Posts
Next >>